Brentuximab Vedotin in the Front-Line Treatment of Patients With CD30+ Peripheral T-Cell Lymphomas: Results of a Phase I Study
Fanale, M. A., Horwitz, S. M., Forero-Torres, A., Bartlett, N. L., Advani, R. H., Pro, B., Chen, R. W., Davies, A., Illidge, T., Huebner, D., Kennedy, D. A., Shustov, A. R.Volume:
32
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2013.54.2456
Date:
October, 2014
File:
PDF, 169 KB
english, 2014